Example: Heart Attack

Clinical Trials on Color Vision Defects

Total 18 results

    • NCT04021914
      Suspended
      Feasibility of EnChroma Use in the Emergency Department Setting
      Conditions: Color Vision Defects
    • NCT04048499
      Completed
      Prevalence and Severity of Colour Vision Deficiency Among Turkish Children
      Conditions: CAD Test; Children's Vision; Colour Assessment; Colour Vision; Turkey
    • NCT01927536
      Completed
      Evaluating Color Perception Under LED Red/Green and Green Dominant Light
      Conditions: Color Blindness, Acquired
    • NCT04606355
      Recruiting
      Autostereoscopic Dynamic Near Vision Testing
      Conditions: Visual Suppression; Amblyopia; Color Vision Defects
    • NCT04060238
      Completed
      Effect of Protanopia on the Brightness Perception of Brake Lights
      Conditions: Color Blindness, Red; Reaction Time
    • NCT04041232
      Not yet recruiting
      PBA Use for Treatment of ATF6-/- Patients
      Conditions: ACHROMATOPSIA 7; Achromatopsia
    • NCT02935517
      Recruiting
      Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 Achromatopsia
      Conditions: Achromatopsia
    • NCT03758404
      Recruiting
      Gene Therapy for Achromatopsia (CNGA3)
      Conditions: Achromatopsia
    • NCT03278873
      Recruiting
      Long-Term Follow-Up Gene Therapy Study for Achromatopsia CNGB3 and CNGA3
      Conditions: Achromatopsia
    • NCT03001310
      Completed
      Gene Therapy for Achromatopsia (CNGB3)
      Conditions: Achromatopsia
    • NCT04124185
      Recruiting
      Natural History Study for Achromatopsia
      Conditions: Achromatopsia
    • NCT02610582
      Active, not recruiting
      Safety and Efficacy of a Single Subretinal Injection of rAAV.hCNGA3 in Patients With CNGA3-linked Achromatopsia
      Conditions: Achromatopsia
    • NCT02599922
      Recruiting
      Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGB3 Achromatopsia
      Conditions: Achromatopsia
    • NCT01846052
      Completed
      Clinical and Genetic Characterization of Individuals With Achromatopsia
      Conditions: Achromatopsia
    • NCT01648452
      Completed
      CNTF Implants for CNGB3 Achromatopsia
      Conditions: Eye Disease; Achromatopsia
    • NCT02909985
      Completed
      Visual Activity Evoked by Infrared in Humans After Dark Adaptation
      Conditions: Age Related Macular Degeneration; Retinitis Pigmentosa; Congenital Stationary Night Blindness; Colorblindness
    • NCT02994030
      Recruiting
      Biomarker for Duchenne Muscular Dystrophy
      Conditions: Increased Lordosis/Scoliosis; Hyporeflexia; Duchenne Muscular Dystrophy; Red-Green Color Blindness; Lordosis; Scoliosis; Muscular Atrophy; Muscular Weakness
    • NCT02435940
      Recruiting
      Inherited Retinal Degenerative Disease Registry
      Conditions: Eye Diseases Hereditary; Retinal Disease; Achromatopsia; Bardet-Biedl Syndrome; Bassen-Kornzweig Syndrome; Batten Disease; Best Disease; Choroidal Dystrophy; Choroideremia; Cone Dystrophy; Cone-Rod Dystrophy; Congenital Stationary Night Blindness; Enhanced S-Cone Syndrome; Fundus Albipunctatus; Goldmann-Favre Syndrome; Gyrate Atrophy; Juvenile Macular Degeneration; Kearns-Sayre Syndrome; Leber Congenital Amaurosis; Refsum Syndrome; Retinitis Pigmentosa; Retinitis Punctata Albescens; Retinoschisis; Rod-Cone Dystrophy; Rod Dystrophy; Rod Monochromacy; Stargardt Disease; Usher Syndrome
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations